3rd Dec 2007 09:19
GlaxoSmithKline Kabushiki Kaisha03 December 2007 GlaxoSmithKline Kabushiki Kaisha€500,000,000 3.25 per cent. Fixed Rate Notes due 2009 With effect from 1 December 2007, GlaxoSmithKline Capital Kabushiki Kaisha hasmerged with and into GlaxoSmithKline Kabushiki Kaisha. Under the laws of Japan,GlaxoSmithKline Kabushiki Kaisha is treated as the same legal entity asGlaxoSmithKline Capital Kabushiki Kaisha and GlaxoSmithKline Kabushiki Kaishahas automatically assumed all the rights and obligations of GlaxoSmithKlineCapital Kabushiki Kaisha as a result of the merger. Pursuant to a fifthsupplemental trust deed dated 30 November 2007 to the principal trust deed dated4 December 2001 (as supplemented and amended) constituting the €500,000,000 3.25per cent. Fixed Rate Notes due 2009, GlaxoSmithKline Kabushiki Kaisha replacedGlaxoSmithKline Capital Kabushiki Kaisha as the principal debtor in respect ofsuch Notes. The Notes continue to be guaranteed by GlaxoSmithKline plc. SM Bicknell3 December 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline